ESR1 and breast carcinoma: Multivariate analysis of the association of tumor ARTEMIN (ARTN) and TWIST1 expression with five-year relapse free (RFS) and overall survival (OS) in patients with estrogen receptor (ER) negative mammary carcinoma (ER-MC).